Super Micro Computer, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Super Micro Computer, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $678.17M | May 17, 2019 |
| FY2017 | Mar 31, 2017 | $614.80M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $663.20M | May 17, 2019 |
| FY2017 | Sep 30, 2016 | $528.76M | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $531.22M | May 17, 2019 |
| FY2017 | Mar 31, 2016 | $513.47M | May 17, 2019 |
| FY2017 | Dec 31, 2015 | $641.24M | May 17, 2019 |
| FY2017 | Sep 30, 2015 | $539.10M | May 17, 2019 |
| FY2017 | Jun 30, 2015 | $1.95B | May 17, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $21.97B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $14.99B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $7.12B | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $5.20B | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $3.56B | Aug 28, 2023 |
| FY2020 | Jun 30, 2020 | $896.13M | Aug 31, 2020 |
| FY2020 | Mar 31, 2020 | $772.41M | Aug 31, 2020 |
| FY2020 | Dec 31, 2019 | $870.94M | Aug 31, 2020 |
| FY2020 | Sep 30, 2019 | $799.80M | Aug 31, 2020 |
| FY2020 | Jun 30, 2019 | $854.23M | Aug 31, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | $524.27M | Aug 26, 2016 |
| FY2016 | Mar 31, 2016 | $532.72M | Aug 26, 2016 |
| FY2016 | Dec 31, 2015 | $638.96M | Aug 26, 2016 |
| FY2016 | Sep 30, 2015 | $519.62M | Aug 26, 2016 |
| FY2016 | Jun 30, 2015 | $573.59M | Aug 26, 2016 |
| FY2016 | Mar 31, 2015 | $471.23M | Aug 26, 2016 |
| FY2016 | Dec 31, 2014 | $503.01M | Aug 26, 2016 |
| FY2016 | Sep 30, 2014 | $443.32M | Aug 26, 2016 |
| FY2015 | Jun 30, 2014 | $428.07M | Nov 16, 2015 |
| FY2015 | Mar 31, 2014 | $373.76M | Nov 16, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.43B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $2.06B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $1.28B | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $800.00M | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $534.54M | Aug 28, 2023 |
| FY2020 | Jun 30, 2020 | $123.52M | Aug 31, 2020 |
| FY2020 | Mar 31, 2020 | $133.36M | Aug 31, 2020 |
| FY2020 | Dec 31, 2019 | $138.40M | Aug 31, 2020 |
| FY2020 | Sep 30, 2019 | $130.93M | Aug 31, 2020 |
| FY2020 | Jun 30, 2019 | $132.03M | Aug 31, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.05B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $1.15B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $640.00M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $285.16M | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $111.87M | Aug 28, 2023 |
| FY2022 | Jun 30, 2020 | $84.31M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $71.92M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $46.17M | Aug 31, 2020 |
| FY2017 | Jun 30, 2017 | $13.26M | May 17, 2019 |
| FY2017 | Mar 31, 2017 | $15.35M | May 17, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.25B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $1.21B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $761.14M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $335.17M | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $123.95M | Aug 28, 2023 |
| FY2022 | Jun 30, 2020 | $85.65M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $97.23M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $94.71M | Aug 31, 2020 |
| FY2019 | Jun 30, 2017 | $94.88M | Dec 19, 2019 |
| FY2017 | Jun 30, 2016 | $107.49M | May 17, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $636.55M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $463.55M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $307.26M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $272.27M | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $224.37M | Aug 28, 2023 |
| FY2022 | Jun 30, 2020 | $221.48M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $179.91M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $165.10M | Aug 31, 2020 |
| FY2019 | Jun 30, 2017 | $143.99M | Dec 19, 2019 |
| FY2017 | Jun 30, 2016 | $124.22M | May 17, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.66B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | ($2.49B) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $663.58M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | ($440.80M) | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $122.96M | Aug 28, 2023 |
| FY2022 | Jun 30, 2020 | ($30.33M) | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $262.55M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $84.35M | Aug 31, 2020 |
| FY2019 | Jun 30, 2017 | ($96.19M) | Dec 19, 2019 |
| FY2017 | Jun 30, 2016 | $107.99M | May 17, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $127.21M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $124.28M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $36.79M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $45.18M | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | $58.02M | Aug 28, 2023 |
| FY2022 | Jun 30, 2020 | $44.34M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $24.85M | Aug 27, 2021 |
| FY2020 | Jun 30, 2018 | $24.82M | Aug 31, 2020 |
| FY2019 | Jun 30, 2017 | $29.37M | Dec 19, 2019 |
| FY2017 | Jun 30, 2016 | $34.11M | May 17, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $14.02B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $9.83B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $3.67B | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | $3.21B | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $2.24B | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $1.92B | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $1.68B | Aug 31, 2020 |
| FY2019 | Jun 30, 2018 | $1.77B | Dec 19, 2019 |
| FY2017 | Jun 30, 2017 | $1.52B | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $1.19B | May 17, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.72B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $4.41B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $1.70B | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | $1.78B | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.15B | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $852.94M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $741.42M | Aug 31, 2020 |
| FY2019 | Jun 30, 2018 | $925.85M | Dec 19, 2019 |
| FY2017 | Jun 30, 2017 | $741.28M | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $494.83M | May 17, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.30B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $5.42B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $1.97B | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | $1.43B | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.10B | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $1.07B | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $941.02M | Aug 31, 2020 |
| FY2019 | Jun 30, 2018 | $843.50M | Dec 19, 2019 |
| FY2017 | Jun 30, 2017 | $773.68M | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $696.47M | May 17, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.43B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $2.59B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $1.43B | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | $942.92M | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $657.76M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $696.21M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $611.90M | Aug 31, 2020 |
| FY2019 | Jun 30, 2018 | $532.27M | Dec 19, 2019 |
| FY2017 | Jun 30, 2017 | $485.97M | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $419.12M | May 17, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.17B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $1.67B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $440.46M | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | $267.40M | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $232.27M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $210.53M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $248.16M | Aug 31, 2020 |
| FY2019 | Jun 30, 2018 | $115.38M | Dec 19, 2019 |
| FY2017 | Jun 30, 2017 | $110.61M | May 17, 2019 |
| FY2017 | Jun 30, 2016 | $178.82M | May 17, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $120.18M | Aug 28, 2023 |
| FY2023 | Jun 30, 2022 | $147.62M | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | $34.70M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $5.70M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | $0 | Aug 31, 2020 |
| FY2014 | Jun 30, 2014 | $46.29M | Sep 15, 2014 |
| FY2013 | Jun 30, 2013 | $35.17M | Sep 11, 2013 |
| FY2013 | Jun 30, 2012 | $32.76M | Sep 11, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 2 | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | 2 | Aug 28, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 31, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 31, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 31, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 31, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 31, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Jun 30, 2021 | 2 | Aug 28, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 31, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 31, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 31, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 31, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 31, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 594.14M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | 588.09M | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | 529.01M | Feb 25, 2025 |
| FY2023 | Jun 30, 2022 | 52.31M | Aug 28, 2023 |
| FY2022 | Jun 30, 2021 | 50.58M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | 52.41M | Aug 27, 2021 |
| FY2020 | Jun 30, 2019 | 49.96M | Aug 31, 2020 |